Li Li

Orally Bioavailable Macrocyclic Peptide That Inhibits Binding of PCSK9 to the Low Density Lipoprotein Receptor

Douglas G. Johns, Louis‐Charles Campeau, Puja Banka et al. · Circulation · 2023 · 141 citations · Full text

Pharmacy, Medicinal Chemistry, Pharmacology +17

Two CYP71AJ enzymes function as psoralen synthase and angelicin synthase in the biosynthesis of furanocoumarins in Peucedanum praeruptorum Dunn

Xiangyun Jian, Yucheng Zhao, Ziwen Wang et al. · Plant Molecular Biology · 2020 · 39 citations

Life Sciences, Botany, Plant Biology +8

Rapid identification of urokinase plasminogen activator inhibitors from Traditional Chinese Medicines based on ultrafiltration, LC–MS and in silico docking

Li Li, Jing Kong, Chun-hua Yao et al. · Journal of Pharmaceutical and Biomedical Analysis · 2018 · 31 citations

Pharmacy, Medicinal Chemistry, Pharmacology +12

Tafolecimab in Chinese Patients With Hypercholesterolemia (CREDIT-4)

Litong Qi, Dexue Liu, Yanling Qu et al. · JACC Asia · 2023 · 30 citations · Full text

Pharmacy, Pharmacology, Pharmacotherapy +17

Tafolecimab in Chinese patients with non-familial hypercholesterolemia (CREDIT-1): a 48-week randomized, double-blind, placebo-controlled phase 3 trial

Yong Huo, Beijian Chen, Qiufang Lian et al. · The Lancet Regional Health - Western Pacific · 2023 · 28 citations · Full text

Pharmacy, Pharmacology, Pharmacotherapy +17